Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionAmalgamated Bank
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Amalgamated Bank closes position in FOLD / Amicus Therapeutics, Inc.

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 0 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 9,360 shares of Amicus Therapeutics, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -100.00 0
2026-02-05 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 9,360 339 3.76 0 0.0010
2025-10-29 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 9,021 -1,203 -11.77 0 0.0005
2025-08-04 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 10,224 0 0.00 0 0.0005
2025-04-25 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 10,224 35 0.34 0 0.0007
2025-02-04 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 10,189 0 0.00 0 0.0008
2024-10-30 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 10,189 0 0.00 0 0.0009
2024-08-12 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 10,189 322 3.26 0 0.0009
2024-04-23 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 9,867 -30,418 -75.51 0 0.0010
2024-02-06 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 40,285 -2,809 -6.52 1 0.0046
2023-11-08 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 43,094 602 1.42 1 0.0045
2023-08-11 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 42,492 3,400 8.70 1 0.0043
2023-05-02 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 39,092 -6,426 -14.12 0 0.0037
2023-02-10 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 45,518 899 2.01 1 -100.00 0.0050
2022-11-09 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 44,619 1,060 2.43 466 -0.43 0.0045
2022-08-15 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 43,559 511 1.19 468 14.71 0.0044
2022-08-25 2022-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 43,048 -3,230 -6.98 408 -23.74 0.0032
2022-06-30 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 43,048 -3,230 408 0.0032
2022-02-15 2021-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 46,278 -502 -1.07 535 19.69 0.0039
2022-02-15 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 46,278 -502 535 0.0039
2021-10-29 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 46,780 -2,881 -5.80 447 -6.68 0.0038
2021-08-16 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 49,661 13,052 35.65 479 32.32 0.0038
2021-05-13 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 36,609 -3,576 -8.90 362 -60.99 0.0136
2021-02-12 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 40,185 647 1.64 928 66.31 0.0352
2020-10-30 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 39,538 -1,159 -2.85 558 -9.12 0.0243
2020-08-10 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 40,697 -3,421 -7.75 614 50.49 0.0284
2020-05-13 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 44,118 -1,388 -3.05 408 -7.90 0.0100
2020-02-13 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 45,506 4,451 10.84 443 34.65 0.0082
2019-11-13 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 41,055 -581 -1.40 329 -36.73 0.0069
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 41,636 12,847 44.62 520 32.65 0.0121
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 28,789 1,174 4.25 392 47.92 0.0095
2019-02-15 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 27,615 16,550 149.57 265 97.76 0.0075
2018-11-14 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 11,065 -17,831 -61.71 134 -70.29 0.0033
2018-07-18 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 28,896 4,011 16.12 451 20.59 0.0110
2018-05-22 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 24,885 2,119 9.31 374 14.02 0.0099
2018-02-13 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 22,766 1,749 8.32 328 3.47 0.0089
2017-11-09 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 21,017 2,566 13.91 317 70.43 0.0099
2017-08-10 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 18,451 1,002 5.74 186 50.00 0.0061
2017-05-12 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 17,449 -30 -0.17 124 42.53 0.0062
2017-02-14 2016-12-31 13F AMICUS THERAPEUTICS COM 03152W109 17,479 2,661 17.96 87 -20.91 0.0039
2016-11-15 2016-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 14,818 1,365 10.15 110 22.22 0.0064
2016-08-16 2016-06-30 13F AMICUS THERAPEUTICS COM 03152W109 13,453 1,238 10.14 90 -12.62 0.0052
2016-05-11 2016-03-31 13F AMICUS THERAPEUTICS COM 03152W109 12,215 1,095 9.85 103 -4.63 0.0100
2016-02-10 2015-12-31 13F AMICUS THERAPEUTICS COM 03152W109 11,120 -1,040 -8.55 108 -36.47 0.0133
2015-11-04 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 12,160 12,160 170 0.0178
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.